STAT+: How a cash-prize system that phases out patents may lower drug prices
Two months ago, Sen. Bernie Sanders (I-Vt.) moved a step closer to an idea he…
Category: Pharmalot
.jpg)
STAT+: Pharmalittle: Cepheid agrees to sell a TB test at cost; Mallinckrodt weighs selling some or all businesses
Top of the morning to you. And a fine one it is. Lots of sunshine…
STAT+: After a high-profile pressure campaign, Cepheid agrees to sell a TB test at cost
Following a high-profile pressure campaign, the company that makes a crucial tuberculosis test has agreed…
STAT+: Pharmalittle: U.S. Chamber and feds clash on Medicare price negotiation; South Africa probes J&J over TB-drug pricing
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: South Africa investigates Johnson & Johnson over ‘excessive pricing’ for its TB drug
South African authorities are investigating Johnson & Johnson and its Janssen subsidiary over “excessive pricing”…
STAT+: Pharmalittle: House panel inches into fixing drug shortages; pharma could face legal action over improper patent listings
And so, another working week will soon draw to a close. Not a moment too…
STAT+: FTC warns drugmakers they can face legal action over improper patent filings
The Federal Trade Commission warned pharmaceutical companies they could face legal action if they improperly…
STAT+: Medicare is urged to monitor how rebates affect Part D drug spending, but agency demurs
The U.S. government should monitor the effect that rebates have on Medicare Part D plans…
STAT+: Pharmalittle: White House imposes price limits for Regeneron Covid drug; lawmakers push federal agencies to prevent patent abuses
Top of the morning to you. And a fine one it is. Lots of sunshine…
Novelist John Green launches attack on Cepheid over the price of its TB test
John Green, a novelist and high-profile YouTuber, is once again leveraging his star power in…
STAT+: Lawmakers introduce bill to require drugmakers to provide key info to both FDA and U.S. Patent Office
Amid concerns over monopolies held by drugmakers, a bipartisan group of lawmakers introduced a bill…
STAT+: Pharmalittle: FDA panel says popular decongestant doesn’t work; U.S. warns companies over illegally marketed eye products
Good morning, everyone, and how are you today? We are doing just fine, thank you….
STAT+: Pharmalittle: Is Pascal Soriot leaving AstraZeneca? PBMs try to counter congressional crackdown
Hello, everyone, and nice to see you again after our extended break. A little time…
STAT+: Pharmalittle: Biden’s NIH nominee will get a hearing; top Democrat backs bill to ban PBM spread pricing
Good morning, Jason Mast here filling in for Ed. Today, I’m drinking a cup of…
STAT+: Pharmalittle: Novartis R&D hub’s name change reflects strategy shift; Lilly’s Mounjaro backed by U.K. watchdog
Good morning, Pharmalittle family! Adam Feuerstein here, filling in for Ed. My morning coffee was…
STAT+: Pharmalittle: South Africa ‘bullied’ into one-sided Covid vaccine deals; Astellas drops Medicare price-negotiation suit
Good morning, everyone. Jason Mast here filling in for Ed. I learned today from TikTok…
STAT+: South Africa was forced into ‘one-sided’ deals with Covid-19 vaccine suppliers, contracts reveal
South Africa was “bullied” into signing one-sided contracts with Covid-19 vaccine suppliers that forced the…
STAT+: Pharmalittle: Novartis is losing its chief commercial officer; vaccine experts urge more inclusivity in clinical trials
Top of the morning to you. And a steamy one, it is. In fact, there…
STAT+: Pharmalittle: Novartis is latest drugmaker to sue over Medicare negotiations; Illumina names a new CEO
Good morning, everyone, and welcome to another working week. We hope the weekend respite —…
STAT+: FTC settles with Amgen over $28 billion deal for Horizon
After months of legal sparring, Amgen and Horizon Therapeutics settled a lawsuit with the U.S….
STAT+: Pharmalittle: How 98 days may cost J&J big bucks; Walgreens CEO departs
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Pharmalittle: U.S. pharma layoffs continue to climb; senators push insulin makers for details of low-cost programs
Top of the morning to you, and a fine one it is. Blue skies and…
STAT+: J&J cuts the price of its life-saving TB pill by more than half for many low and middle-income countries
Amid controversy over access to a life-saving tuberculosis pill, a new contracting effort is expected…
STAT+: Pharmalittle: Winners and losers from Medicare drug-negotiation list; Novo strikes deal to keep lead in weight-loss drugs
Good morning, everyone, and welcome to the middle of the week. Congratulations on making it…
STAT+: Pharmalittle: U.S. selects first 10 drugs for Medicare price negotiations; Pfizer may soon restart tornado-hit plant
Top of the morning to you. Gray skies are hovering over the Pharmalot campus right…
STAT+: FDA delays enforcement of a pharmaceutical supply chain law to stop counterfeit drugs
In response to growing complaints, the U.S. Food and Drug Administration has postponed its plans…
STAT+: Pharmalittle: FTC suspends challenge to Amgen deal for Horizon; AstraZeneca is latest to challenge Medicare drug negotiations
Good morning, everyone, and nice to see you again after a week-long respite, during which…
STAT+: Pharmalittle: This fall’s COVID booster rollout; approval for Pfizer’s RSV vaccine
Good morning Pharmalittle students. This is Allison DeAngelis, filling in for Ed Silverman while he’s…
STAT+: Pharmalittle: Mid-year price hikes for U.S. drugs reaches new heights; onetime biotech CEO Vivek Ramaswamy sparks debate at GOP debate
Good morning, Pharmalittle readers. Reporter Andrew Joseph here filling in for Ed from STAT’s London…
STAT+: Pharmalittle: Roche data on immunotherapy accidentally released; Novo Nordisk hires Thermo Fisher to manufacture Wegovy
Hello and happy Wednesday from STAT’s London outpost, with Andrew Joseph here filling in for…
STAT+: FDA approves Pfizer’s RSV vaccine for newborns; Boehringer sues over IRA
Good morning, one and all. Damian Garde here, filling in for Ed Silverman once more…
STAT+: Pharmalittle: Weight loss drugs cost much more in the U.S.; PBMs win a key victory over an Oklahoma law
And so, another working week will soon draw to a close. Not a moment too…
STAT+: ViiV Healthcare and Doctors Without Borders tussle over contract terms for an HIV drug
A feud has erupted between ViiV Healthcare and Doctors Without Borders over a deal to…
STAT+: U.S. appeals court strike down key provisions in Oklahoma law that regulates PBMs
A U.S. appeals court struck down key parts of an Oklahoma law designed to regulate…
STAT+: Pharmalittle: U.S. appeals court upholds limits to abortion pill; ‘knock-off’ Ozempic thrives on ‘bogus’ website
Top of the morning to you. And a steamy one, it is. In fact, there…
STAT+: South Africa ordered to disclose contracts with Pfizer, J&J, and other Covid-19 vaccine makers
A South African court ruled the government must disclose contracts signed with pharmaceutical companies for…
STAT+: In a rare move, FDA threatens to fine a company for failing to report clinical trial results
For only the fifth time, the U.S. Food and Drug Administration recently threatened to fine…
STAT+: Pharmalittle: Chinese drugmakers develop copycat weight loss drugs; SEC eyes supplier of research monkeys
Rise and shine, everyone. The middle of the week is upon us. Have heart, though….
STAT+: FDA warns AstraZeneca over misleading promotional materials for a COPD drug
The U.S. Food and Drug Administration scolded AstraZeneca for making misleading claims about the effectiveness…
STAT+: SEC wants to know if key supplier of research monkeys bribed foreign officials
A U.S. government probe into a monkey-smuggling operation emanating from Cambodia has gone in a…
STAT+: Pharmalittle: Amazon Pharmacy offers insulin discounts; DOJ blasts industry attempt to delay Medicare drug-price talks
Hello, everyone, and how are you today? A steely gray sky is hovering this morning…
STAT+: Pharmalittle: White House drug-shortage panel is MIA with lawmakers; Ultragenyx sued by Lacks family
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: More hospital pharmacists are rationing drugs due to increasing shortages
Nearly every hospital pharmacy across the U.S. is experiencing shortages of prescription drugs. And the…
STAT+: Pharmalittle: Supreme Court halts Purdue bankruptcy plan; what to know about compounded obesity drugs
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Supreme Court blocks Purdue bankruptcy plan that would shield Sacklers from lawsuits
The U.S. Supreme Court blocked a nationwide settlement with Purdue Pharma that was designed to…
STAT+: EPA fines Roche’s Genentech unit for hazardous waste violations
Following an extensive inspection, the U.S. Environmental Protection Agency fined Genentech more than $158,000 for…
STAT+: What to know about concerns raised about compounded versions of Novo Nordisk’s Wegovy
As demand for Ozempic and Wegovy surges, a little noticed warning about the medicines was…
STAT+: Pharmalittle: Genentech weighs delaying cancer therapy after drug pricing law; Novo continues to restrict supplies of low-dose Wegovy
Rise and shine, everyone, another very busy day awaits. Even so, there is nothing like…
STAT+: Pharmalittle: Wegovy heart study has docs seeing new possibilities; drugmakers file more ‘continuation’ patents that sideline generic rivals
Good morning, everyone, and how are you today? We are doing just fine, thank you….
STAT+: More drugmakers are filing continuation patents that sideline generic competition
Amid concerns that the pharmaceutical industry unfairly wins monopolies on medicines, a new analysis finds…